Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 24456)

Published in Proc Natl Acad Sci U S A on December 07, 1999

Authors

D Huang1, G Patrick, J Moffat, L H Tsai, B Andrews

Author Affiliations

1: Department of Molecular Genetics, University of Toronto, 1 Kings College Circle, Toronto, Canada M5S 1A8.

Articles citing this

Function and regulation in MAPK signaling pathways: lessons learned from the yeast Saccharomyces cerevisiae. Biochim Biophys Acta (2007) 3.07

Some assembly required: yeast septins provide the instruction manual. Trends Cell Biol (2005) 1.96

The BAR domain proteins: molding membranes in fission, fusion, and phagy. Microbiol Mol Biol Rev (2006) 1.94

Nutrient sensing and signaling in the yeast Saccharomyces cerevisiae. FEMS Microbiol Rev (2014) 1.59

Diphosphoinositol polyphosphates: metabolic messengers? Mol Pharmacol (2009) 1.41

Evolution of networks and sequences in eukaryotic cell cycle control. Philos Trans R Soc Lond B Biol Sci (2011) 1.30

Targeted disruption of the murine Bin1/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation. Mol Cell Biol (2003) 1.26

Activation of the Cdc42p GTPase by cyclin-dependent protein kinases in budding yeast. EMBO J (2007) 1.20

Dissection of a complex phenotype by functional genomics reveals roles for the yeast cyclin-dependent protein kinase Pho85 in stress adaptation and cell integrity. Mol Cell Biol (2002) 1.19

BAR the door: cancer suppression by amphiphysin-like genes. Biochim Biophys Acta (2008) 1.12

Genetic evidence for a morphogenetic function of the Saccharomyces cerevisiae Pho85 cyclin-dependent kinase. Genetics (2001) 1.08

Reuse, replace, recycle. Specificity in subunit inheritance and assembly of higher-order septin structures during mitotic and meiotic division in budding yeast. Cell Cycle (2009) 1.00

Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis. J Exp Med (2010) 0.99

Structure of the Pho85-Pho80 CDK-cyclin complex of the phosphate-responsive signal transduction pathway. Mol Cell (2007) 0.98

Regulation of the yeast amphiphysin homologue Rvs167p by phosphorylation. Mol Biol Cell (2003) 0.97

Inositol pyrophosphates: why so many phosphates? Adv Biol Regul (2014) 0.90

Regulation of cell polarity through phosphorylation of Bni4 by Pho85 G1 cyclin-dependent kinases in Saccharomyces cerevisiae. Mol Biol Cell (2009) 0.90

Understanding inositol pyrophosphate metabolism and function: kinetic characterization of the DIPPs. FEBS Lett (2013) 0.89

Coevolution of cyclin Pcl5 and its substrate Gcn4. Eukaryot Cell (2005) 0.89

Yeast Gcn4p stabilization is initiated by the dissociation of the nuclear Pho85p/Pcl5p complex. Mol Biol Cell (2006) 0.86

Autophosphorylation-induced degradation of the Pho85 cyclin Pcl5 is essential for response to amino acid limitation. Mol Cell Biol (2008) 0.83

Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with a loss-of-function mutation in CDK5. Hum Genet (2015) 0.81

Redundancy or specificity? The role of the CDK Pho85 in cell cycle control. Int J Biochem Mol Biol (2013) 0.79

Degradation of Saccharomyces cerevisiae transcription factor Gcn4 requires a C-terminal nuclear localization signal in the cyclin Pcl5. Eukaryot Cell (2009) 0.78

Identification of a lifespan extending mutation in the Schizosaccharomyces pombe cyclin gene clg1+ by direct selection of long-lived mutants. PLoS One (2013) 0.77

New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition. J Biol Chem (2013) 0.76

Acid phosphatases of budding yeast as a model of choice for transcription regulation research. Enzyme Res (2011) 0.75

Articles cited by this

A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics (1989) 105.30

Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast (1998) 48.29

Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol (1997) 9.87

Morphogenesis in the yeast cell cycle: regulation by Cdc28 and cyclins. J Cell Biol (1993) 6.28

MAP kinase pathways in the yeast Saccharomyces cerevisiae. Microbiol Mol Biol Rev (1998) 6.20

A family of human cdc2-related protein kinases. EMBO J (1992) 4.96

Phosphorylation of the transcription factor PHO4 by a cyclin-CDK complex, PHO80-PHO85. Science (1994) 4.24

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95

Signaling phosphate starvation. Trends Biochem Sci (1996) 3.07

A brain-specific activator of cyclin-dependent kinase 5. Nature (1994) 2.71

Role of phosphorylation in regulation of the assembly of endocytic coat complexes. Science (1998) 2.60

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev (1996) 2.59

Phosphate-regulated inactivation of the kinase PHO80-PHO85 by the CDK inhibitor PHO81. Science (1994) 2.57

SBF cell cycle regulator as a target of the yeast PKC-MAP kinase pathway. Science (1997) 2.47

The PCL2 (ORFD)-PHO85 cyclin-dependent kinase complex: a cell cycle regulator in yeast. Science (1994) 2.41

The cyclin family of budding yeast: abundant use of a good idea. Trends Genet (1998) 2.40

The crystal structure of cyclin A. Structure (1995) 2.28

Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns. Mol Cell Biol (1993) 2.23

Protein traffic in the yeast endocytic and vacuolar protein sorting pathways. Curr Opin Cell Biol (1998) 2.13

Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (1993) 2.09

Cyclin partners determine Pho85 protein kinase substrate specificity in vitro and in vivo: control of glycogen biosynthesis by Pcl8 and Pcl10. Mol Cell Biol (1998) 2.04

The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature (1998) 2.01

Cell cycle control by a complex of the cyclin HCS26 (PCL1) and the kinase PHO85. Science (1994) 1.94

The amphiphysin family of proteins and their role in endocytosis at the synapse. Trends Neurosci (1998) 1.72

A family of cyclin-like proteins that interact with the Pho85 cyclin-dependent kinase. Mol Cell Biol (1997) 1.72

Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem (1996) 1.63

The transcription factor, the Cdk, its cyclin and their regulator: directing the transcriptional response to a nutritional signal. EMBO J (1994) 1.60

Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J Biol Chem (1998) 1.36

Interaction of yeast Rvs167 and Pho85 cyclin-dependent kinase complexes may link the cell cycle to the actin cytoskeleton. Curr Biol (1998) 1.22

Cyclins, cyclin-dependent kinases and differentiation. Bioessays (1997) 1.19

Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J Neurosci (1998) 1.18

In vivo analysis of the domains of yeast Rvs167p suggests Rvs167p function is mediated through multiple protein interactions. Genetics (1999) 1.06

Structure-function relationships of the yeast cyclin-dependent kinase Pho85. Mol Cell Biol (1995) 0.98

Neuronal Cdc2-like kinases: neuron-specific forms of Cdk5. Int J Biochem Cell Biol (1997) 0.96

Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator. Kinase activation in the absence of Cdk5 phosphorylation. J Biol Chem (1995) 0.95

Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator. Evidence of the existence of cyclin fold in neuronal Cdk5a activator. J Biol Chem (1997) 0.87

Articles by these authors

Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science (2001) 24.48

Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol (2000) 12.65

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature (1999) 5.53

A decade of CDK5. Nat Rev Mol Cell Biol (2001) 5.24

A family of human cdc2-related protein kinases. EMBO J (1992) 4.96

Psychopathology and early experience: a reappraisal of retrospective reports. Psychol Bull (1993) 4.66

The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J (1996) 4.65

A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol (1996) 4.61

Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell (1995) 4.48

Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature (2000) 4.31

Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50

NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron (2000) 3.45

Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem (1997) 3.20

Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron (1997) 2.96

Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82

Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat Cell Biol (2000) 2.81

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev (1996) 2.59

SBF cell cycle regulator as a target of the yeast PKC-MAP kinase pathway. Science (1997) 2.47

The PCL2 (ORFD)-PHO85 cyclin-dependent kinase complex: a cell cycle regulator in yeast. Science (1994) 2.41

Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13

Cyclin partners determine Pho85 protein kinase substrate specificity in vitro and in vivo: control of glycogen biosynthesis by Pcl8 and Pcl10. Mol Cell Biol (1998) 2.04

The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature (1998) 2.01

Identification of the prfC gene, which encodes peptide-chain-release factor 3 of Escherichia coli. Proc Natl Acad Sci U S A (1994) 2.00

Acute stress disorder and posttraumatic stress disorder in victims of violent crime. Am J Psychiatry (1999) 1.95

p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci (2001) 1.87

Harvesting the genome's bounty: integrative genomics. Cold Spring Harb Symp Quant Biol (2003) 1.84

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum (1999) 1.75

Social support, self-esteem and depression. Psychol Med (1986) 1.73

A family of cyclin-like proteins that interact with the Pho85 cyclin-dependent kinase. Mol Cell Biol (1997) 1.72

Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem Biol (2000) 1.71

An essential component of a C-terminal domain phosphatase that interacts with transcription factor IIF in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1997) 1.70

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology (2001) 1.65

Categorizing neonatal deaths: a cross-cultural study in the United States, Canada, and The Netherlands. J Pediatr (2010) 1.64

p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem (1998) 1.63

Structure and regulation of the CDK5-p25(nck5a) complex. Mol Cell (2001) 1.57

Transcriptional coregulation by the cell integrity mitogen-activated protein kinase Slt2 and the cell cycle regulator Swi4. Mol Cell Biol (2001) 1.43

Fear, helplessness, and horror in posttraumatic stress disorder: investigating DSM-IV criterion A2 in victims of violent crime. J Trauma Stress (2000) 1.42

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42

Comparative hazards of chrysotile asbestos and its substitutes: A European perspective. Environ Health Perspect (1999) 1.39

Role of the casein kinase I isoform, Hrr25, and the cell cycle-regulatory transcription factor, SBF, in the transcriptional response to DNA damage in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1997) 1.36

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther (2001) 1.35

Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. J Biol Chem (2000) 1.31

Regulation of the yeast DNA replication genes through the Mlu I cell cycle box is dependent on SWI6. Proc Natl Acad Sci U S A (1992) 1.25

Interaction of yeast Rvs167 and Pho85 cyclin-dependent kinase complexes may link the cell cycle to the actin cytoskeleton. Curr Biol (1998) 1.22

Cdk5 on the brain. Cell Growth Differ (2001) 1.21

Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum (1999) 1.16

Traumatic brain injury in the rat: characterization of a midline fluid-percussion model. Cent Nerv Syst Trauma (1987) 1.16

Traumatic diaphragmatic herniation presenting as a delayed tension faecopneumothorax. Emerg Med J (2006) 1.15

The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc Natl Acad Sci U S A (1996) 1.15

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma. Cancer (2001) 1.14

Passive sound localization of prey by the pallid bat (Antrozous p. pallidus). J Comp Physiol A (1993) 1.12

Crisis support and psychiatric symptomatology in adult survivors of the Jupiter cruise ship disaster. Br J Clin Psychol (1992) 1.12

Regulation of cell cycle transcription factor Swi4 through auto-inhibition of DNA binding. Mol Cell Biol (1999) 1.10

The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev (1997) 1.09

The kinetics of influx of calcium and strontium into rat intestine in vitro. J Physiol (1970) 1.09

A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol (1998) 1.07

Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. J Neurosci (2001) 1.07

In vivo analysis of the domains of yeast Rvs167p suggests Rvs167p function is mediated through multiple protein interactions. Genetics (1999) 1.06

Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol (2000) 1.06

Self-esteem and depression. II. Social correlates of self-esteem. Soc Psychiatry Psychiatr Epidemiol (1990) 1.03

Metered-dose inhaler technique of patients in an urban ED: prevalence of incorrect technique and attempt at education. Am J Emerg Med (1996) 1.00

The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model. J Antimicrob Chemother (1993) 0.98

Functions of Pho85 cyclin-dependent kinases in budding yeast. Prog Cell Cycle Res (2000) 0.98

Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. Eur J Pharmacol (2000) 0.97

Effects of publicity and a warning letter on illegal cigarette sales to minors. Aust J Public Health (1994) 0.96

Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor. J Pharmacol Exp Ther (1996) 0.94

Letter: Mycoplasma pneumoiae in a tubo-ovarian abscess. Lancet (1975) 0.94

Affinity selection from peptide libraries to determine substrate specificity of protein tyrosine phosphatases. Anal Biochem (1998) 0.94

Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres. Carcinogenesis (2000) 0.94

Abdominal sepsis managed by leaving abdomen open. Surgery (1981) 0.93

Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse. J Neurocytol (1997) 0.93

Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res (1998) 0.92

Biparietal diameter in premature rupture of membranes: errors in estimating gestational age. J Clin Ultrasound (1983) 0.92

Interactions between Pho85 cyclin-dependent kinase complexes and the Swi5 transcription factor in budding yeast. Mol Microbiol (2000) 0.92

The early effect of pelvic floor muscle exercise after transurethral prostatectomy. J Urol (1998) 0.91

Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J Neurochem (1996) 0.91

Cannabinoid properties of methylfluorophosphonate analogs. J Pharmacol Exp Ther (2000) 0.91

Patterns of lymphatic drainage to individual thoracic and cervical lymph nodes in the rat. Lab Anim (1987) 0.91

Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells. J Cell Physiol (2001) 0.90

A quantitative study of the penetration of insoluble particles into the tissue of the conducting airways. Ann Occup Hyg (1982) 0.90

Structural analyses of various Cu2+, Zn2+-superoxide dismutases by differential scanning calorimetry and Raman spectroscopy. Arch Biochem Biophys (1985) 0.90

Self-esteem and depression. III. Aetiological issues. Soc Psychiatry Psychiatr Epidemiol (1990) 0.90

A yeast taf17 mutant requires the Swi6 transcriptional activator for viability and shows defects in cell cycle-regulated transcription. Genetics (2000) 0.89

The role of glutamine and glucose analogues in metabolic inhibition of human myeloid leukaemia in vitro. Int J Biochem (1993) 0.89

Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol Biochem Behav (1988) 0.89

Crisis support in the aftermath of disaster: a longitudinal perspective. Br J Clin Psychol (1993) 0.88

Callosal axon guidance defects in p35(-/-) mice. J Comp Neurol (1999) 0.88

Backbone 1H, 15N, and 13C resonance assignments of inhibitor-2 -- a protein inhibitor of protein phosphatase-1. J Biomol NMR (2000) 0.88

The role of the p35/cdk5 kinase in cortical development. Results Probl Cell Differ (2000) 0.88

Industrial atmospheric pollution, historical land use patterns and mortality. J Public Health Med (1996) 0.87

The protein kinase Pho85 is required for asymmetric accumulation of the Ash1 protein in Saccharomyces cerevisiae. Mol Microbiol (2001) 0.87

The retention of particles in large airways of the respiratory tract. Proc R Soc Lond B Biol Sci (1977) 0.87